Literature DB >> 20054187

Circulating markers of inflammation and their link to indices of adiposity.

Lucy M Browning1, Jeremy D Krebs, Edel C Magee, Gema Frühbeck, Susan A Jebb.   

Abstract

BACKGROUND: Adipose tissue produces a number of inflammatory mediators. Circulating concentrations of these inflammatory markers are increasingly used as markers of local or systemic inflammation. This study compares results for 3 inflammatory adipokines measured using 2 techniques, (multiplex and ELISA), and determines the relationships with C-reactive protein (CRP), obesity, and the impact of moderate weight loss. SUBJECTS AND METHODS: Fasting blood samples were collected at baseline and after a 24-week weight loss intervention. Interleukin 6 (IL-6), tumour necrosis factor alpha(TNF-alpha), and monocyte chemoattractant protein 1 (MCP-1) were measured using a standard ELISA technique or a new multiplex technique. A total of 54 women with complete data were included in this analysis.
RESULTS: Multiplex showed poor correlation with ELISA results, and were not significantly correlated with CRP. Using ELISA data, IL-6 and CRP were significantly correlated with body mass index (BMI) (r = 0.42 and r = 0.55), but MCP-1 and TNF-alpha were not (r = - 0.07 and r = 0.06). Changes in MCP-1, TNF-alpha, and IL-6 were not significantly different between control and weight loss groups. CRP was significantly reduced in weight loss vs. control group (p < 0.05), and change in CRP correlated with change in BMI (r = 0.31).
CONCLUSION: Circulating IL-6 and CRP, but not MCP-1 and TNF-alpha, are significantly associated with indices of adiposity in obese women. This study suggests that circulating IL-6 and CRP, but not MCP-1 and TNF-alpha, are useful markers of obesity-related inflammation.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 20054187      PMCID: PMC2802719          DOI: 10.1159/000169832

Source DB:  PubMed          Journal:  Obes Facts        ISSN: 1662-4025            Impact factor:   3.942


  27 in total

1.  Elevated levels of interleukin 6 are reduced in serum and subcutaneous adipose tissue of obese women after weight loss.

Authors:  J P Bastard; C Jardel; E Bruckert; P Blondy; J Capeau; M Laville; H Vidal; B Hainque
Journal:  J Clin Endocrinol Metab       Date:  2000-09       Impact factor: 5.958

2.  Changes in risk factors for cardiovascular disease with body fat loss in obese women.

Authors:  J D Krebs; S Evans; L Cooney; G D Mishra; G Fruhbeck; N Finer; S A Jebb
Journal:  Diabetes Obes Metab       Date:  2002-11       Impact factor: 6.577

3.  Impact of weight loss on the metabolic syndrome.

Authors:  C C Case; P H Jones; K Nelson; E O'Brian Smith; C M Ballantyne
Journal:  Diabetes Obes Metab       Date:  2002-11       Impact factor: 6.577

4.  C-reactive protein and other markers of inflammation in the prediction of cardiovascular disease in women.

Authors:  P M Ridker; C H Hennekens; J E Buring; N Rifai
Journal:  N Engl J Med       Date:  2000-03-23       Impact factor: 91.245

5.  Markers of chronic inflammation and obesity: a prospective study on the reversibility of this association in middle-aged women undergoing weight loss by surgical intervention.

Authors:  M Laimer; C F Ebenbichler; S Kaser; A Sandhofer; H Weiss; H Nehoda; F Aigner; J R Patsch
Journal:  Int J Obes Relat Metab Disord       Date:  2002-05

6.  C-reactive protein, interleukin 6, and risk of developing type 2 diabetes mellitus.

Authors:  A D Pradhan; J E Manson; N Rifai; J E Buring; P M Ridker
Journal:  JAMA       Date:  2001-07-18       Impact factor: 56.272

7.  Energy restriction and weight loss on very-low-fat diets reduce C-reactive protein concentrations in obese, healthy women.

Authors:  L K Heilbronn; M Noakes; P M Clifton
Journal:  Arterioscler Thromb Vasc Biol       Date:  2001-06       Impact factor: 8.311

8.  C-reactive protein is independently associated with total body fat, central fat, and insulin resistance in adult women.

Authors:  N Pannacciulli; F P Cantatore; A Minenna; M Bellacicco; R Giorgino; G De Pergola
Journal:  Int J Obes Relat Metab Disord       Date:  2001-10

9.  Reduction of inflammatory cytokine concentrations and improvement of endothelial functions in obese women after weight loss over one year.

Authors:  Patrizia Ziccardi; Francesco Nappo; Giovanni Giugliano; Katherine Esposito; Raffaele Marfella; Michele Cioffi; Francesco D'Andrea; Anna Maria Molinari; Dario Giugliano
Journal:  Circulation       Date:  2002-02-19       Impact factor: 29.690

10.  C-reactive protein is an independent predictor of risk for the development of diabetes in the West of Scotland Coronary Prevention Study.

Authors:  Dilys J Freeman; John Norrie; Muriel J Caslake; Allan Gaw; Ian Ford; Gordon D O Lowe; Denis St J O'Reilly; Chris J Packard; Naveed Sattar
Journal:  Diabetes       Date:  2002-05       Impact factor: 9.461

View more
  15 in total

1.  Markers of inflammation and coagulation may be modulated by enteral feeding strategy.

Authors:  Julie A Bastarache; Lorraine B Ware; Timothy D Girard; Arthur P Wheeler; Todd W Rice
Journal:  JPEN J Parenter Enteral Nutr       Date:  2012-02-07       Impact factor: 4.016

2.  Predictors of Subclinical Inflammatory Obesity: Plasma Levels of Leptin, Very Low-Density Lipoprotein Cholesterol and CD14 Expression of CD16+ Monocytes.

Authors:  Fernanda Leite; Ângela Leite; Ana Santos; Margarida Lima; Joselina Barbosa; Marco Cosentino; Laura Ribeiro
Journal:  Obes Facts       Date:  2017-07-22       Impact factor: 3.942

Review 3.  Inflammation in maternal obesity and gestational diabetes mellitus.

Authors:  P Pantham; I L M H Aye; T L Powell
Journal:  Placenta       Date:  2015-04-28       Impact factor: 3.481

4.  Relation between C-reactive protein and impaired fasting glucose in obese subjects.

Authors:  Luis E Simental-Mendía; Brissia Lazalde; Graciela Zambrano-Galván; Luis Simental-Saucedo; Elizabeth Rábago-Sánchez; Martha Rodríguez-Morán; Fernando Guerrero-Romero
Journal:  Inflammation       Date:  2012-10       Impact factor: 4.092

5.  Morbid obesity and inflammation: a prospective study after adjustable gastric banding surgery.

Authors:  Renata Ramalho; Cristina Guimarães; Cidália Gil; Celestino Neves; João Tiago Guimarães; Luís Delgado
Journal:  Obes Surg       Date:  2009-05-14       Impact factor: 4.129

6.  Relationship among circulating inflammatory proteins, platelet gene expression, and cardiovascular risk.

Authors:  David D McManus; Lea M Beaulieu; Eric Mick; Kahraman Tanriverdi; Martin G Larson; John F Keaney; Emelia J Benjamin; Jane E Freedman
Journal:  Arterioscler Thromb Vasc Biol       Date:  2013-08-22       Impact factor: 8.311

7.  Dairy Foods in a Moderate Energy Restricted Diet Do Not Enhance Central Fat, Weight, and Intra-Abdominal Adipose Tissue Losses nor Reduce Adipocyte Size or Inflammatory Markers in Overweight and Obese Adults: A Controlled Feeding Study.

Authors:  Marta D Van Loan; Nancy L Keim; Sean H Adams; Elaine Souza; Leslie R Woodhouse; Anthony Thomas; Megan Witbracht; Erik R Gertz; Brian Piccolo; Andrew A Bremer; Michael Spurlock
Journal:  J Obes       Date:  2011-09-14

8.  Specific Inflammatory Stimuli Lead to Distinct Platelet Responses in Mice and Humans.

Authors:  Lea M Beaulieu; Lauren Clancy; Kahraman Tanriverdi; Emelia J Benjamin; Carolyn D Kramer; Ellen O Weinberg; Xianbao He; Samrawit Mekasha; Eric Mick; Robin R Ingalls; Caroline A Genco; Jane E Freedman
Journal:  PLoS One       Date:  2015-07-06       Impact factor: 3.240

9.  Increased methylation of interleukin 6 gene is associated with obesity in Korean women.

Authors:  Yeon Kyung Na; Hae Sook Hong; Won Kee Lee; Young Hun Kim; Dong Sun Kim
Journal:  Mol Cells       Date:  2015-04-28       Impact factor: 5.034

10.  Effect of CPAP treatment on endothelial function and plasma CRP levels in patients with sleep apnea.

Authors:  Athanasios Panoutsopoulos; Anastasios Kallianos; Konstantinos Kostopoulos; Charalampos Seretis; Eleni Koufogiorga; Athanasios Protogerou; Georgia Trakada; Charalampos Kostopoulos; Nikolaos Zakopoulos; Ioannis Nikolopoulos
Journal:  Med Sci Monit       Date:  2012-12
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.